AT385510B - Verfahren zur herstellung von neuen 10-alkinylsteroiden - Google Patents

Verfahren zur herstellung von neuen 10-alkinylsteroiden

Info

Publication number
AT385510B
AT385510B AT0285781A AT285781A AT385510B AT 385510 B AT385510 B AT 385510B AT 0285781 A AT0285781 A AT 0285781A AT 285781 A AT285781 A AT 285781A AT 385510 B AT385510 B AT 385510B
Authority
AT
Austria
Prior art keywords
alkinyl
steroids
producing new
producing
new
Prior art date
Application number
AT0285781A
Other languages
English (en)
Other versions
ATA285781A (de
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ATA285781A publication Critical patent/ATA285781A/de
Application granted granted Critical
Publication of AT385510B publication Critical patent/AT385510B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0285781A 1980-06-27 1981-06-26 Verfahren zur herstellung von neuen 10-alkinylsteroiden AT385510B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16345180A 1980-06-27 1980-06-27

Publications (2)

Publication Number Publication Date
ATA285781A ATA285781A (de) 1987-09-15
AT385510B true AT385510B (de) 1988-04-11

Family

ID=22590066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0285781A AT385510B (de) 1980-06-27 1981-06-26 Verfahren zur herstellung von neuen 10-alkinylsteroiden

Country Status (23)

Country Link
US (1) US4322416A (de)
JP (1) JPS5738797A (de)
AT (1) AT385510B (de)
AU (1) AU542273B2 (de)
BE (1) BE889401A (de)
CA (1) CA1173431A (de)
CH (1) CH646984A5 (de)
DE (1) DE3124780A1 (de)
DK (2) DK161151C (de)
ES (1) ES8302025A1 (de)
FR (1) FR2485543A1 (de)
GB (2) GB2078749B (de)
HK (1) HK72686A (de)
IE (1) IE51351B1 (de)
IL (1) IL63143A (de)
IT (1) IT1171339B (de)
MY (1) MY8700055A (de)
NL (1) NL8103101A (de)
NO (1) NO156693C (de)
NZ (1) NZ197494A (de)
PH (1) PH16787A (de)
SE (1) SE452325B (de)
ZA (1) ZA814220B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100566B1 (de) * 1982-07-14 1986-02-19 Akzo N.V. 19-Thioandrostan-Derivate
ATE37871T1 (de) * 1982-12-21 1988-10-15 Ciba Geigy Ag Substituierte azabicycloalkane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
DE3338212C2 (de) * 1983-10-18 1995-05-18 Schering Ag 1-Methyl-androsta-1,4,6-trien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
US4634694A (en) * 1984-01-14 1987-01-06 Akzo N.V. Novel Δ4 - and Δ5 -androstene derivatives and pharmaceutical compositions containing these derivatives
US4546098A (en) * 1984-04-13 1985-10-08 The Rockefeller University Estrogen synthesis inhibitors
FR2569408B1 (fr) * 1984-08-24 1986-10-03 Roussel Uclaf Nouveaux steroides substitues en position 10 par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
FR2594830B1 (fr) * 1986-02-24 1988-06-03 Roussel Uclaf Nouveaux 13 epi ou d-homo steroides substitues en position 10b par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
FR2594829B1 (fr) * 1986-02-24 1988-06-03 Roussel Uclaf Nouveaux steroides 9 (11) satures substitues en position 10 par un radical comportant une triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
US4874891A (en) * 1986-05-01 1989-10-17 Washington University Open "D" ring hormone analogs
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds
FR2640976B1 (de) * 1988-12-22 1994-10-28 Roussel Uclaf
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
US5126488A (en) * 1990-11-30 1992-06-30 Merrell Dow Pharmaceuticals Inc. 2β,19-methyleneamino bridged steroids as aromatase inhibitors
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
FR2677027B1 (fr) * 1991-05-27 1993-09-10 Roussel Uclaf Nouveaux produits sterouides substitues en position 6, et comportant, en position 10, un radical thioethyle, leur procede de preparation leurs intermediaires, leur application comme medicaments.
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
US5866558A (en) * 1997-05-08 1999-02-02 Regents Of The University Of Minnesota 6-alkynyl steroids
EP1854465A1 (de) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Verwendung von 4,17 beta-dihydroxyandrost-4-ene-3-one zur Behandlung von Krebs
CN102884072A (zh) 2010-04-08 2013-01-16 爱默蕾大学 被取代的雄甾-4-烯二酮
EP3666276A1 (de) 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medikament gegen östrogen-rezeptor-beta (erbeta)-positiven brusttumor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127427A (en) * 1962-07-17 1964-03-31 Hoffmann La Roche 10-alkenyl-steroids and process therefor
US3218316A (en) * 1963-08-26 1965-11-16 Syntex Corp 10beta-ethynyl-19-norandrostane derivatives

Also Published As

Publication number Publication date
ATA285781A (de) 1987-09-15
NO156693B (no) 1987-07-27
DE3124780C2 (de) 1992-04-23
DK161151C (da) 1991-11-18
AU542273B2 (en) 1985-02-14
NL192455B (de) 1997-04-01
GB2135314B (en) 1985-04-17
CA1173431A (en) 1984-08-28
IL63143A0 (en) 1981-09-13
GB2078749A (en) 1982-01-13
IE51351B1 (en) 1986-12-10
NO812197L (no) 1981-12-28
PH16787A (en) 1984-02-22
US4322416A (en) 1982-03-30
DK161151B (da) 1991-06-03
ZA814220B (en) 1982-07-28
NZ197494A (en) 1984-11-09
ES503345A0 (es) 1983-01-01
CH646984A5 (de) 1984-12-28
MY8700055A (en) 1987-12-31
GB2135314A (en) 1984-08-30
DK162447C (da) 1992-03-23
SE8103963L (sv) 1981-12-28
NL192455C (de) 1997-08-04
IT8148780A0 (it) 1981-06-26
IL63143A (en) 1984-10-31
GB2078749B (en) 1983-11-16
GB8316702D0 (en) 1983-07-20
IT1171339B (it) 1987-06-10
DK162447B (da) 1991-10-28
NL8103101A (nl) 1982-01-18
NO156693C (no) 1987-11-04
IE811434L (en) 1981-12-27
FR2485543A1 (fr) 1981-12-31
ES8302025A1 (es) 1983-01-01
DK274681A (da) 1981-12-28
DK75190A (da) 1990-03-22
JPS5738797A (en) 1982-03-03
DK75190D0 (da) 1990-03-22
SE452325B (sv) 1987-11-23
JPH021159B2 (de) 1990-01-10
BE889401A (fr) 1981-12-28
AU7237081A (en) 1982-01-07
HK72686A (en) 1986-10-03
DE3124780A1 (de) 1982-06-03
FR2485543B1 (de) 1983-12-23

Similar Documents

Publication Publication Date Title
AT378768B (de) Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
AT385510B (de) Verfahren zur herstellung von neuen 10-alkinylsteroiden
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
ATA125383A (de) Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
ATA206483A (de) Verfahren zur herstellung von neuen mitosanderivaten
AT382638B (de) Verfahren zur herstellung von neuen trehaloselipiden
AT376654B (de) Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
AT386602B (de) Verfahren zur herstellung von 17alpha-acyloxy-20 -keto-21-halogensteroiden
AT380683B (de) Verfahren zur herstellung von neuen diaminophenolaethern
AT379388B (de) Verfahren zur herstellung von neuen 4-chinolonderivaten
AT376679B (de) Verfahren zur herstellung von neuen bisindolalkaloiden
ATA138979A (de) Verfahren zur herstellung von neuen steroiden
AT375076B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
AT373231B (de) Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden
AT374451B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT373891B (de) Verfahren zur herstellung von neuen rifamycinderivaten
AT381940B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT381939B (de) Verfahren zur herstellung von neuen azaspiroalkandionen
ATA354581A (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten
AT378776B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
ATA67481A (de) Verfahren zur herstellung von neuen androstancarbothioaten

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELJ Ceased due to non-payment of the annual fee